193 related articles for article (PubMed ID: 32972047)
1. A Preoperative Nomogram for Predicting Chemoresistance to Neoadjuvant Chemotherapy in Patients with Locally Advanced Cervical Squamous Carcinoma Treated with Radical Hysterectomy.
Ou Z; Zhao D; Li B; Wang Y; Liu S; Zhang Y
Cancer Res Treat; 2021 Jan; 53(1):233-242. PubMed ID: 32972047
[TBL] [Abstract][Full Text] [Related]
2. Preoperative nomogram for prediction of microscopic parametrial infiltration in patients with FIGO stage IB cervical cancer treated with radical hysterectomy.
Kong TW; Kim J; Son JH; Kang SW; Paek J; Chun M; Chang SJ; Ryu HS
Gynecol Oncol; 2016 Jul; 142(1):109-114. PubMed ID: 27179979
[TBL] [Abstract][Full Text] [Related]
3. Radical Hysterectomy After Neoadjuvant Chemotherapy for Locally Bulky-Size Cervical Cancer: A Retrospective Comparative Analysis between the Robotic and Abdominal Approaches.
Liu CH; Lee YC; Lin JC; Chan IS; Lee NR; Chang WH; Liu WM; Wang PH
Int J Environ Res Public Health; 2019 Oct; 16(20):. PubMed ID: 31614465
[TBL] [Abstract][Full Text] [Related]
4. [Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy].
Li PP; Li B; Wang YT; Liu SH; Zhang YN; Zhang R; Bai P; Li XG; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):248-256. PubMed ID: 29747270
[No Abstract] [Full Text] [Related]
5. Comparison of survival outcomes of neoadjuvant therapy and direct surgery in IB2/IIA2 cervical adenocarcinoma: a retrospective study.
Ouyang P; Cai J; Gui L; Liu S; Wu NY; Wang J
Arch Gynecol Obstet; 2020 May; 301(5):1247-1255. PubMed ID: 32221709
[TBL] [Abstract][Full Text] [Related]
6. Platinum-based neoadjuvant chemotherapy followed by radical surgery for cervical carcinoma international federation of gynecology and obstetrics stage IB2-IIB.
Minig L; Colombo N; Zanagnolo V; Landoni F; Bocciolone L; Cárdenas-Rebollo JM; Iodice S; Maggioni A
Int J Gynecol Cancer; 2013 Nov; 23(9):1647-54. PubMed ID: 24100590
[TBL] [Abstract][Full Text] [Related]
7. Postoperative nomogram predicting risk of recurrence after radical hysterectomy for early-stage cervical cancer.
Kim MK; Jo H; Kong HJ; Kim HC; Kim JW; Kim YM; Song YS; Kang SB; Mok JE; Lee HP
Int J Gynecol Cancer; 2010 Dec; 20(9):1581-6. PubMed ID: 21370600
[TBL] [Abstract][Full Text] [Related]
8. Postoperative nomogram for the prediction of disease-free survival in lymph node-negative stage I-IIA cervical cancer patients treated with radical hysterectomy.
Gülseren V; Kocaer M; Çakır İ; Özdemir İA; Sancı M; Güngördük K
J Obstet Gynaecol; 2020 Jul; 40(5):699-704. PubMed ID: 31607197
[TBL] [Abstract][Full Text] [Related]
9. Safety and Efficacy of Neoadjuvant Chemotherapy Followed by Radical Surgery Versus Radical Surgery Alone in Locally Advanced Cervical Cancer Patients.
Gong L; Zhang JW; Yin RT; Wang P; Liu H; Zheng Y; Lou JY; Peng ZL
Int J Gynecol Cancer; 2016 May; 26(4):722-8. PubMed ID: 26905330
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment serum hemoglobin level as a predictive factor of response to neoadjuvant chemotherapy in patients with locally advanced squamous cervical carcinoma: a preliminary report.
Fuso L; Mazzola S; Marocco F; Ferrero A; Dompè D; Carus AP; Zola P
Gynecol Oncol; 2005 Dec; 99(3 Suppl 1):S187-91. PubMed ID: 16185756
[TBL] [Abstract][Full Text] [Related]
11. [Effects of pre-chemotherapy hemoglobin and platelet levels in patients with stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy followed by radical hysterectomy].
Wang D; Wu M; Ren T; Wan XR; Feng FZ; Huang HF; Yang JX; Shen K; Xiang Y
Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):577-81. PubMed ID: 23141176
[TBL] [Abstract][Full Text] [Related]
12. Pretreatment platelet and hemoglobin levels are neither predictive nor prognostic variables for patients with locally advanced cervical cancer treated with neoadjuvant chemotherapy and radical hysterectomy: a retrospective Italian study.
Gadducci A; Cosio S; Zola P; Tisi G; Ferrero A; Piovano E; Cristofani R; Greco C; Sartori E
Int J Gynecol Cancer; 2010 Nov; 20(8):1399-404. PubMed ID: 21051984
[TBL] [Abstract][Full Text] [Related]
13. Tumor-infiltrating CD8+ and FOXP3+ lymphocytes before and after neoadjuvant chemotherapy in cervical cancer.
Liang Y; Lü W; Zhang X; Lü B
Diagn Pathol; 2018 Nov; 13(1):93. PubMed ID: 30474571
[TBL] [Abstract][Full Text] [Related]
14. Follow-up in a long-term randomized trial with neoadjuvant chemotherapy for squamous cell cervical carcinoma.
Mossa B; Mossa S; Corosu L; Marziani R
Eur J Gynaecol Oncol; 2010; 31(5):497-503. PubMed ID: 21061788
[TBL] [Abstract][Full Text] [Related]
15. The Outcome of Locally Advanced Cervical Cancer in Patients Treated with Neoadjuvant Chemotherapy Followed by Radical Hysterectomy and Primary Surgery.
Mousavi A; Modarres Gilani M; Akhavan S; Sheikh Hasani S; Alipour A; Gholami H
Iran J Med Sci; 2021 Sep; 46(5):355-363. PubMed ID: 34539010
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant chemotherapy for patients with international federation of gynecology and obstetrics stages IB3 and IIA2 cervical cancer: a multicenter prospective trial.
Hu Y; Han Y; Shen Y; Chen J; Chen Y; Chen Y; Tang J; Xue M; Hong L; Cheng W; Wang D; Liang Z; Wang Y; Zhang Q; Xing H; Zhang Y; Yi C; Yu Z; Chen Y; Cui M; Ma C; Yang H; Li R; Long P; Zhao Y; Qu P; Tao G; Yang L; Wu S; Liu Z; Yang P; Lv W; Xie X; Ma D; Wang H; Li K
BMC Cancer; 2022 Dec; 22(1):1270. PubMed ID: 36471257
[TBL] [Abstract][Full Text] [Related]
17. Impact of neoadjuvant chemotherapy on the postoperative pathology of locally advanced cervical squamous cell carcinomas: 1:1 propensity score matching analysis.
Li P; Fang Z; Li W; Hao M; Wang W; Kang S; Guo J; Yang Y; Ni Y; Zhao W; Lu A; Ling B; Li D; Lang J; Chen C; Liu P
Eur J Surg Oncol; 2021 May; 47(5):1069-1074. PubMed ID: 32980212
[TBL] [Abstract][Full Text] [Related]
18. Outcome of patients with bulky IB (≥ 6 cm) cervical squamous cell carcinoma with and without cisplatin-based neoadjuvant chemotherapy.
Wang PH; Chang YH; Yang YH; Chang WH; Huang SY; Lai CR; Juang CM; Chen YJ; Horng HC; Wen KC; Ng HT; Yuan CC; Chao KC; Yen MS
Taiwan J Obstet Gynecol; 2014 Sep; 53(3):330-6. PubMed ID: 25286786
[TBL] [Abstract][Full Text] [Related]
19. Definite chemoradiotherapy is a competent treatment option in FIGO stage IB2 cervical cancer compared with radical surgery +/- neoadjuvant chemotherapy.
Hsieh HY; Huang JW; Lu CH; Lin JC; Wang L
J Formos Med Assoc; 2019 Jan; 118(1 Pt 1):99-108. PubMed ID: 29429800
[TBL] [Abstract][Full Text] [Related]
20. Establishing a Nomogram for Stage IA-IIB Cervical Cancer Patients after Complete Resection.
Zhou H; Li X; Zhang Y; Jia Y; Hu T; Yang R; Huang KC; Chen ZL; Wang SS; Tang FX; Zhou J; Chen YL; Wu L; Han XB; Lin ZQ; Lu XM; Xing H; Qu PP; Cai HB; Song XJ; Tian XY; Zhang QH; Shen J; Liu D; Wang ZH; Xu HB; Wang CY; Xi L; Deng DR; Wang H; Lv WG; Shen K; Wang SX; Xie X; Cheng XD; Ma D; Li S
Asian Pac J Cancer Prev; 2015; 16(9):3773-7. PubMed ID: 25987036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
